|
 | | Identify
key clinical factors related to antiretroviral sequencing and the importance of
this strategy to avoid viral resistance. |
|
|
| | Recognize
new antiretroviral drugs in late clinical trials, as well as their potential place
in HAART therapy. |
|
|
| | Highlight
tools to identify risk factors, detect, and treat hepatitis co-infections in patients
with HIV/AIDS. |
|
|
| | Examine
the pathogenesis of HIV infection, including the stages of progression, and which
opportunistic infections and malignancies HIV patients may be at higher risk for
developing. |
|
|
| | Assess
epidemiologic issues related to both the global and US epidemic of HIV/AIDS. |
|
|
| | Understand
and implement important techniques to ensure adherence with HAART regimens and
avoid side effects and toxicities. |
|
|
|
